A House Energy and Commerce subcommittee convened the hearing to assess the current forecast for this flu season, federal efforts to mitigate illnesses, and ongoing research into new flu vaccines and treatments.
Topics of discussion included common reasons the general public does not opt to get a flu vaccine; the importance of supporting local health departments to track flu data; and the U.S.’s domestic manufacturing capacity for flu vaccines, medications and other supplies in case of a flu pandemic.
The following health officials testified at the hearing:
- Nancy Messonnier, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases
- Anthony Fauci, MD, director of NIH’s National Institute for Allergy and Infectious Diseases
- Robert Kadlec, MD, assistant secretary for preparedness and response for HHS
- Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research
More articles on clinical leadership & infection control:
Everything you need to know about Seattle Children’s mold issues
10 states report widespread flu activity
Care interrupted for 200+ patients at Hawaii hospital after physician accused of sexual assault
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.